- Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsionJean Haensler
Sanofi Pasteur R and D, Marcy l Etoile, France Electronic address
Int J Pharm 486:99-111. 2015....
- [Introduction to novel vaccine adjuvants and their role in influenza vaccination]J Haensler
Discovery R and D, Sanofi Pasteur, Campus Merieux, 1541, avenue Marcel Mérieux, 69280 Marcy l Etoile, France
Ann Pharm Fr 71:104-8. 2013..Nevertheless, the development of new adjuvants remains challenging in terms of quality and safety assurance and in terms of clinical and industrial development costs...